Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Integrated Platform for Measuring and Reducing Symptoms of Autism Spectrum Disorder — Stella

Home/Autism Spectrum Disorder/Integrated Platform for Measuring and Reducing Symptoms of Autism Spectrum Disorder

View on ClinicalTrials.gov

Recruiting

Back to Autism Spectrum Disorder trials

Integrated Platform for Measuring and Reducing Symptoms of Autism Spectrum Disorder

Not a traditional drug trial — this study doesn't follow the standard phase structure.

Trial locations(2 sites)

United States

Mt. Sinai Medical Center, New York, New York

Golisano Center for Special Needs, Syracuse, New York

Key details

Sponsor

State University of New York - Upstate Medical University

Collaborators

JelikaLite LLC, Mt. Sinai School of Medicine, New York, New York

Enrollment target

~80 participants

Started

October 2023

Primary completion

August 2026

Age range

2 Years – 8 Years

Last updated October 2025

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.